logo

For the Inventor, By the Inventor

Ashiya, Japan

Sachio Mori

This inventor holds 10 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1984-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sachio Mori. Retrieved from https://idiyas.com/inventor/sachio-mori-fewnisb6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 28(Granted Patents)


Location History:

  • Hyogo, JP (1984 - 1990)
  • Ashiya, JP (1995 - 1998)

Company Filing History:

goldMedal10 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 1984-1998

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5731455 - Lignan analogues, methods of preparation thereof and anti-hyperlipemic (1998-03-24),
2. 5502216 - Lignan analogues, methods of preparation thereof and anti-hyperlipemic (1996-03-26),
3. 5488134 - Preparation of compounds of lignan series (1996-01-30),
4. 5449814 - Lignan analogues, methods of preparation thereof and anti-hyperlipemic (1995-09-12),
5. 5420333 - Lignan analogues, methods of preparation thereof and anti-hyperlipemic (1995-05-30),
6. 4902811 - Benzodioxane prostacyclin analogs (1990-02-20),
7. 4855449 - Prostacyclin (PGI.sub.2) analogues (1989-08-08),
8. 4820836 - Prostacyclin (PGI.sub.2) analogues (1989-04-11),
9. 4552841 - N-Acetyl-.beta.-D-glucosaminides for determining (1985-11-12),
10. 4433139 - N-Acetyl-.beta.-D-glucosamnides for determining (1984-02-21),

Title: The Innovations of Sachio Mori

Introduction

Sachio Mori is a prominent inventor based in Ashiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-hyperlipemic agents. With a total of 10 patents to his name, Mori's work has had a substantial impact on health and wellness.

Latest Patents

One of Mori's latest patents focuses on lignan analogues and methods of preparation thereof, which serve as an anti-hyperlipemic agent. This agent exhibits potent activity in reducing LDL and VLDL cholesterols, which are considered risk factors for arteriosclerosis. The patent also highlights the antioxidant activity on LDL, providing a promising avenue for cardiovascular health. The compound is represented by a specific formula, detailing various substituents that enhance its efficacy.

Career Highlights

Mori has dedicated his career to research and innovation in the pharmaceutical industry. His work at Shionogi & Company Limited has allowed him to collaborate with other talented professionals and contribute to groundbreaking advancements in medicine. His expertise in the field has positioned him as a key figure in the development of effective treatments for cholesterol management.

Collaborations

Mori has worked alongside notable colleagues such as Shozo Takechi and Shiro Kida. Their combined efforts have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sachio Mori's contributions to the field of pharmaceuticals through his patents and collaborations have made a lasting impact on health science. His dedication to innovation continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…